Authors: TAGLIAFERRI P BARILE C CARAGLIA M GUARRASI R MORELLI D RICCIARDI B MARTIGNETTI A LIBRERA MT MATANO E DELLAVECCHIA A CATALANO G FAMIANI M PALMIERI G CORREALE P BIANCO AR

Citation: P. Tagliaferri et al., DAILY LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 BY ALTERNATE WEEKLY ADMINISTRATION - ANTITUMOR-ACTIVITY AND IMMUNOMODULATORY EFFECTS, American journal of clinical oncology, 21(1), 1998, pp. 48-53

Authors: COSTANTINI M MENCAGLIA E DIGIULIO P CORTESI E ROILA F BALLATORI E TAMBURINI M CASALI P LICITRA L MASSIDDA B LUZZANI M CAMPORA E DEPLACIDO S PALMERI S PALLADINO MA BARACCO G GARERI R MARTIGNETTI A RAGOSA S ZODA L IONTA MT BULLETTI S PASTORE L

Citation: M. Costantini et al., ASSESSING QUALITY-OF-LIFE IN ONCOLOGY - R ATIONALE AND OBJECTIVES OF THE FIRST-PHASE OF THE QVONC PROJECT, Tumori, 83(2), 1997, pp. 25-27

Authors: MORABITO A PERRONE F LAURIA R CARLOMAGNO C MARINELLI A DELAURENTIIS M MARTIGNETTI A PETTINATO G PANICO L PETRELLA G GALLO C BIANCO AR DEPLACIDO S

Citation: A. Morabito et al., PROGNOSTIC-SIGNIFICANCE OF MULTIFOCALITY IN PRIMARY BREAST-CANCER, Oncology Reports, 1(6), 1994, pp. 1045-1048